1.Evaluation of efficacy and safety of loratadine in the treatment of childhood asthma.
Gulibaha MAIMAITI ; Abulaiti ABDUHAER ; Pei-Ru XU
Chinese Journal of Contemporary Pediatrics 2011;13(11):873-877
OBJECTIVETo evaluate the efficacy and safety of loratadine, a new generation of antihistaminics, in the treatment of childhood asthma.
METHODSThe papers related to loratadine treatment for childhood asthma were searched in the database of PubMed, MEDLINE, EMBASE, Cochrance, CNKI and CBMdisc (January 1990 to December 2010) electronically and manually. According to the Cochrane reviewer's handbook, the quality of the enrolled papers was assessed and a systematic review was performed.
RESULTSA total of 179 papers were obtained. Eleven randomized controlled trials met the criteria and were included in this study. The 11 trials included 317 children with asthma: 159 cases in the loratadine treatment group and 158 cases in the control group. All included studies belonged to the B class according to the quality evaluation criteria. Meta analysis showed that the clinical symptoms were improved more, the forced expiratory volume in 1 second (FEV1) 4 and 8 weeks posttreatment and the peak expiratory flow rate (PEFR) 8 weeks posttreatment were higher in the loratadine treatment group than in the control group. The treatment-related adverse effects, fatigue, tachycardia and palpitation, occurred less in the loratadine treatment group compared with the control group.
CONCLUSIONSLoratadine is safe and effective for the treatment of childhood asthma.
Anti-Allergic Agents ; therapeutic use ; Asthma ; drug therapy ; physiopathology ; Forced Expiratory Volume ; Humans ; Loratadine ; adverse effects ; therapeutic use ; Peak Expiratory Flow Rate
3.Effects of Add-On Therapy with NDC-052, an Extract from Magnoliae Flos, in Adult Asthmatic Patients Receiving Inhaled Corticosteroids.
Chan Sun PARK ; Tae Bum KIM ; Jae Young LEE ; Jae Yong PARK ; Yong Chul LEE ; Seong Su JEONG ; Yang Deok LEE ; You Sook CHO ; Hee Bom MOON
The Korean Journal of Internal Medicine 2012;27(1):84-90
BACKGROUND/AIMS: There is a need for new anti-asthmatic medications with fewer side effects. NDC-052, an extract of the medicinal herb Magnoliae flos, which has a long history of clinical use, was recently found to have anti-inflammatory effects. Herein, we evaluated the effects of NDC-052 as an add-on therapy in patients with mild to moderate asthma using inhaled corticosteroids (ICS). METHODS: In a non-comparative, multi-center trial, 148 patients taking ICS received NDC-052 for eight weeks. We evaluated their forced expiratory volume in one second (FEV1), morning and evening peak expiratory flow rate (AM and PM PEFR), AM/PM asthma symptom scores, visual analogue symptom (VAS) scores, night-time wakening, frequency of short-acting beta2-agonist usage, and adverse events. RESULTS: After eight weeks, both AM and PM PEFRs were significantly improved. Asthma symptom scores, VAS scores, the frequency of nights without awakening, and the frequency of beta2-agonist use were also reduced. Most of the adverse drug reactions were mild and resolved spontaneously. CONCLUSIONS: The addition of NDC-052 to ICS had a beneficial effect on asthma control in patients with mild to moderate asthma, with good tolerability and fewer side effects. Further studies are necessary to evaluate the effects of NDC-052 in patients with severe and/or refractory asthma.
Administration, Inhalation
;
Adrenal Cortex Hormones/*administration & dosage
;
Adrenergic beta-2 Receptor Agonists/therapeutic use
;
Adult
;
Anti-Asthmatic Agents/administration & dosage/*therapeutic use
;
Asthma/diagnosis/*drug therapy/physiopathology
;
Drug Therapy, Combination
;
Drugs, Chinese Herbal/*therapeutic use
;
Female
;
Forced Expiratory Volume
;
Humans
;
Lung/drug effects/physiopathology
;
*Magnolia
;
Male
;
Middle Aged
;
Peak Expiratory Flow Rate
;
Prospective Studies
;
Republic of Korea
;
Severity of Illness Index
;
Time Factors
;
Treatment Outcome
4.Effects of Personal Exposure to Nitrogen Dioxide on Peak Expiratory Flow in Asthmatic Patients.
Ho Jang KWON ; Sang Gyu LEE ; Young Koo JEE ; Sang Rok LEE ; Seung Sik HWANG
Journal of Preventive Medicine and Public Health 2007;40(1):59-63
OBJECTIVES: Nitrogen dioxide (NO2) has been inconsistently associated with gradual decreases in lung function. Here, we studied the effects of NO2 exposure in asthmatics by examining the association between changes in lung function and concentrations of NO2 which were personally measured. METHODS: Peak expiratory flow (PEF) and daily personal exposures to NO2 were recorded on 28 patients with asthma (confirmed by methacholine provocation test) over 4 weeks. We used generalized estimating equations to assess the relationship between personal NO2 exposure and PEF, adjusting for potential confounders such as age, gender, outdoor particulate matter, temperature, humidity, and exposure to environmental tobacco smoke. RESULTS: The personal NO2 exposures were higher than the corresponding ambient levels. The mean personal: ambient ratio for NO2 was 1.48. The personal NO2 exposures were not associated with the morning PEF, evening PEF, or the diurnal PEF variability. However, environmental tobacco smoke was negatively associated with both the morning and evening PEF. CONCLUSIONS: Among the asthmatic adults who participated in this study, we found no apparent impact of personal NO2 exposures on the peak expiratory flow.
Tobacco Smoke Pollution/adverse effects/analysis
;
Time Factors
;
Peak Expiratory Flow Rate/*drug effects
;
Nitrogen Dioxide/*adverse effects
;
Male
;
Lung/*drug effects/physiology
;
Korea/epidemiology
;
Inhalation Exposure/*adverse effects/analysis
;
Humans
;
Female
;
Asthma/epidemiology/*physiopathology
;
Air Pollution, Indoor/adverse effects/analysis